Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

Blood

Volumn 97, Issue 1, 2001, Pages 264-269

  Jing, Yongkui ^a   Wang, Long ^b   Xia, Lijuan ^b   Chen, Guo Qiang ^b   Chen, Zhu ^b   Miller, Wilson H ^b   Waxman, Samuel ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; GLUTATHIONE PEROXIDASE; RETINOIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER REGRESSION; CHINESE MEDICINE; FEMALE; GENE INDUCTION; LEUKEMIA CELL; LEUKEMOGENESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; WESTERN BLOTTING;

EID: 0035161286     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.264     Document Type: Article

References (47)

1. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
2. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
3. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
4. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
5. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
6. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy
7. The biology and treatment of acute progranulocytic leukemia
8. Therapy of acute promyelocytic leukemia: All-trans retinoic acid and beyond
9. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia
10. 3) in the treatment of acute promyelocytic leukemia (APL), II: Clinical efficacy and pharmacokinetics in relapsed patients
11. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
12. The enigma of arsenic carcinogenesis: Role of metabolism
13. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
14. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells
15. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
16. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide dependent pathway
17. Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity
18. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
19. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
20. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells
21. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway
22. Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
23. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells
24. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
25. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines
26. Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha
27. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents
28. Myeloperoxidase: Its structure and expression during myeloid differentiation
29. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases
30. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell
31. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity
32. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells
33. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice
34. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
35. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner
36. Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia
37. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia
38. The PML and PML/RARalpha domains: From autoimmunity to molecular oncology and from retinoic acid to arsenic
39. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells
40. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA
41. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: A RING may link hematopoiesis and growth control
42. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response
43. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells
44. Altered sensitivity to retinoid-induced apoptosis associated with changes in the subcellular distribution of Bcl-2
45. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
46. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
47. A1 demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death